LinKinVax, a clinical-stage biotech company, has announced the manufacture and bottling of a GMP batch of its next generation pan-sarbecovirus vaccines, known as PanCov, designed to prevent COVID-19 and other known coronavirus diseases.

Related Keywords

France , French , Alain Sainsot , Jacques Auberton Herv , World Health Organisation , Markets Amp Regulations , Covid 19 , Covid 19 Vaccine , Pandemic ,